GG 159 (Clemastine 1.34 mg)
Pill imprint GG 159 has been identified as Clemastine fumarate 1.34 mg.
Clemastine is used in the treatment of urticaria; allergic reactions; allergic rhinitis and belongs to the drug class antihistamines. There is no proven risk in humans during pregnancy. Clemastine 1.34 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- GG 159
- Strength:
- 1.34 mg
- Color:
- White
- Shape:
- Elliptical / Oval
- Availability:
- Rx and/or OTC
- Drug Class:
- Antihistamines
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Sandoz Pharmaceuticals Inc.
- National Drug Code (NDC):
- 00781-1358
- Inactive Ingredients:
- lactose monohydrate
corn starch
microcrystalline cellulose
hypromellose 2910 (3 mPa.s)
sodium starch glycolate type A potato
magnesium stearate
| NDC Code | Manufacturer / Repackager |
|---|---|
| 54868-5913 | Physicians Total Care Inc (repackager) |
Note: Inactive ingredients may vary.
More about clemastine
Consumer resources
- Other brands: Tavist, Allerhist-1, Tavist-1, Tavist Allergy
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
